|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/755 | (2006.01) |
| A61K 38/36 | (2006.01) | ||
| A61K 38/37 | (2006.01) | ||
| A61P 7/04 | (2006.01) |
| (11) | Number of the document | 3360895 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18159816.0 |
| Date of filing the European patent application | 2015-06-08 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 14171579 | 2014-06-06 | EP |
| (72) |
Kannicht, Christoph , DE
Solecka-Witulska, Barbara , DE
Kohla, Guido , DE
Winge, Stefan , SE
|
| (73) |
Octapharma AG ,
Seidenstrasse 2, 8853 Lachen,
CH
|
| (54) | PREPARATION COMPRISING FACTOR VIII AND VON WILLEBRAND FACTOR PEPTIDES |
| PREPARATION COMPRISING FACTOR VIII AND VON WILLEBRAND FACTOR PEPTIDES |